The Chemours Company
CC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $5 | $5 | $6 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $4 | $4 | $4 | $4 |
| Enterprise Value | $6 | $8 | $7 | $8 |
| Revenue | $6 | $6 | $7 | $6 |
| % Growth | -4.9% | -11% | 7.7% | – |
| Gross Profit | $1 | $1 | $2 | $1 |
| % Margin | 19.9% | 21.5% | 23.7% | 21.8% |
| EBITDA | $1 | $0 | $1 | $1 |
| % Margin | 12% | 3.2% | 17.5% | 18.6% |
| Net Income | $0 | -$0 | $1 | $1 |
| % Margin | 1.5% | -3.9% | 8.5% | 9.6% |
| EPS Diluted | 0.57 | -1.6 | 3.65 | 3.6 |
| % Growth | 135.6% | -143.8% | 1.4% | – |
| Operating Cash Flow | -$1 | $1 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | $0 | $0 | $1 |